Cargando…

Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy

BACKGROUND: Renin-angiotensin system inhibitors (RASi) are the first choice and basic therapy for the treatment of IgA nephropathy (IgAN) with proteinuria. However, approximately 40% of patients have no response to RASi treatment. The aim of this study was to screen potential biomarkers for predicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianping, Wei, Xiaona, Li, Jiajia, Gan, Yangang, Zhang, Rui, Han, Qianqian, Liang, Peifen, Zeng, Yuchun, Yang, Qiongqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459338/ https://www.ncbi.nlm.nih.gov/pubmed/36091017 http://dx.doi.org/10.3389/fimmu.2022.978315

Ejemplares similares

Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy
por: Wu, Jianping, et al.
Publicado: (2022)

Association between geriatric nutritional risk index and pathological phenotypes of IgA nephropathy
por: Gan, Yangang, et al.
Publicado: (2023)

Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients
por: Guo, Na, et al.
Publicado: (2020)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy
por: Li, Zizhen, et al.
Publicado: (2022)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy
por: Zeng, Honghui, et al.
Publicado: (2021)

Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy
por: Abe, Michiaki, et al.
Publicado: (2015)

Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis
por: Sugiura, Naoko, et al.
Publicado: (2021)

The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
por: Wang, Li, et al.
Publicado: (2019)

Increasing prescription of renin–angiotensin–aldosterone system blockers associated with improved kidney prognosis in Korean IgA nephropathy patients
por: Park, Sehoon, et al.
Publicado: (2020)

Efficacy and Safety of Renin-Angiotensin Aldosterone System Inhibitor in Patients with IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: ZHAO, Yu, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Chen, Ming, et al.
Publicado: (2022)

Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
por: Cai, Fengtao, et al.
Publicado: (2023)

Identifying DUSP-1 and FOSB as hub genes in immunoglobulin A nephropathy by WGCNA and DEG screening and validation
por: Jianping, Wu, et al.
Publicado: (2022)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs
por: Huo, Zhihao, et al.
Publicado: (2021)

Retracted: Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
por: International, Emergency Medicine
Publicado: (2023)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Plasma oxidative stress level of IgA nephropathy in children and the effect of early intervention with angiotensin-converting enzyme inhibitors
por: Pei, Yuxin, et al.
Publicado: (2016)

Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study
por: Park, Sehoon, et al.
Publicado: (2019)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades [Volume 31, Issue 3, September 2012, Pages 163–169]
por: Yun Yang, Byeong, et al.
Publicado: (2013)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

The effect of angiotensin type 1 receptor blockade on adhesion molecules in patients with IgA nephropathy
por: Xydakis, Dimitris, et al.
Publicado: (2008)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mjg213liutnrn583i2a8gdvbal